Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 4, 2025 • 12:41 PM ET

Date/Time Source News Release
05/13/2025 04:30 PM EDT GlobeNewswire Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results
04/29/2025 08:00 AM EDT GlobeNewswire Annovis Bio Appoints Hui Liu as Director of Biostatistics
03/27/2025 04:30 PM EDT GlobeNewswire Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE
03/25/2025 08:00 AM EDT GlobeNewswire Annovis to Attend AD/PD(TM) 2025 with Extensive Scientific Program
03/21/2025 05:05 PM EDT GlobeNewswire Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
03/11/2025 08:00 AM EDT GlobeNewswire Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment
02/19/2025 08:30 AM EST GlobeNewswire Annovis to Host Patients' Live Forum on February 27, 2025
02/07/2025 08:00 AM EST GlobeNewswire Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
02/05/2025 08:00 AM EST GlobeNewswire Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer's Disease
02/04/2025 04:31 PM EST GlobeNewswire Annovis Bio, Inc. Announces Closing of $21 Million Public Offering
Page